Chunghwa Chemical Synthesis Biotechs Sluggish Earnings Might Be Just The Beginning Of Its Problems - Simply Wall St
| 1762 Stock | TWD 34.00 1.65 4.63% |
Slightly above 62% of Chunghwa Chemical's investor base is looking to short. The analysis of current outlook of investing in Chunghwa Chemical Synthesis suggests that many traders are alarmed regarding Chunghwa Chemical's prospects. Chunghwa Chemical's investing sentiment can be driven by a variety of factors including economic data, Chunghwa Chemical's earnings reports, geopolitical events, and overall market trends.
Chunghwa Chemical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Chunghwa daily returns and investor perception about the current price of Chunghwa Chemical Synthesis as well as its diversification or hedging effects on your existing portfolios.
Chunghwa |
Chunghwa Chemical Synthesis Biotechs Sluggish Earnings Might Be Just The Beginning Of Its Problems Simply Wall St
Read at news.google.com
 |
Chunghwa Chemical Fundamental Analysis
We analyze Chunghwa Chemical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chunghwa Chemical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chunghwa Chemical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Chunghwa Chemical is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Chunghwa Chemical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chunghwa Chemical stock to make a market-neutral strategy. Peer analysis of Chunghwa Chemical could also be used in its relative valuation, which is a method of valuing Chunghwa Chemical by comparing valuation metrics with similar companies.
Peers
Chunghwa Chemical Related Equities
| 3164 | GenMont Biotech | 0.74 |
| ||
| 3705 | YungShin Global | 1.09 |
| ||
| 4133 | Abnova Taiwan | 1.22 |
| ||
| 1734 | Sinphar Pharmaceutical | 2.50 |
| ||
| 4108 | Phytohealth Corp | 2.72 |
|
Additional Tools for Chunghwa Stock Analysis
When running Chunghwa Chemical's price analysis, check to measure Chunghwa Chemical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chunghwa Chemical is operating at the current time. Most of Chunghwa Chemical's value examination focuses on studying past and present price action to predict the probability of Chunghwa Chemical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chunghwa Chemical's price. Additionally, you may evaluate how the addition of Chunghwa Chemical to your portfolios can decrease your overall portfolio volatility.